The Iranian cyberattack on Stryker is the kind of stress test that business continuity and disaster recovery programs often do not plan for.
Pfizer to close Ignite, its R&D services unit for small biotechs
Pfizer is shutting its Pfizer Ignite unit, according to regulatory disclosures, drawing down operations at a group that was meant to build relationships with early-stage startups. The unit provided input from experts and received fees …
A simpler form of DNA may be key to non-viral gene therapy, study suggests
There’s no more iconic shape in biology than the twisting strands of DNA. Yet that same double helix that makes the molecule instantly recognizable may also be the very thing holding back cheaper, safer, and …
Biotech startups use funding extensions to sidestep full capital rounds
A handful of biotech startups have recently taken an increasingly popular route of financing: extending existing rounds rather than taking on a whole new fundraising campaign. If “money is like oxygen for biotechs,” in the …
Data Governance Lessons From an Unvalidated Dataset
Post Content
Sandoz reorg ahead of ‘golden decade’ for biosimilars; Sanofi to shed Latin America generics business
Sandoz said it will separate its biosimilar unit from generics, since both businesses have different manufacturing and commercial needs. The move is ahead of what it calls a “golden decade” for …
What Orgs Can Learn From Olympics, World Cup IR Plans
In this Reporters’ Notebook, we discuss cyberattackers targeting the Milan-Cortina Winter Games, adding them to a long list of global sporting events in the crosshairs. Though the attack surface is grander, there are key defense takeaways for regular enterprises too.
Iran hackers claim cyberattack at US medtech firm
Cyberattack by an Iranian group against Stryker points to a shift in strategy from extortive to destructive assaults, as geopolitical conflicts rise.
Ipsen appoints Michelle Werner as North America head
Ipsen has appointed biopharma industry veteran Michelle Werner, who recently stepped down as CEO of Alltrna, to lead its North America division.
‘Closed-loop’ AI clinical care is coming soon, startups predict
The startups that are building tools for tasks historically done by clinicians think AI-only healthcare is coming soon. In the next two years, UpDoc co-founder and CEO Sharif Vakili predicted there will be AI agents …
Compounders prescribing GLP-1s put pricing pressure on Novo, Lilly
Hims won — for now. Since 2022, telehealth companies and compounding pharmacies have brought a new type of competition for drugmakers. Pharma giants, long protected by patents and market exclusivity, suddenly found themselves undercut on price …
Pragmatic by design: Engineering AI for the real world
The impact of artificial intelligence extends far beyond the digital world and into our everyday lives, across the cars we drive, the appliances in our homes, and medical devices that keep people alive. More and more, product engineers are turning to AI to enhance, validate, and streamline the design of the items that furnish our […]